Emergent BioSolutions Inc. (NYSE: EBS) will respond to two solicitations issued by the Department of Health and Human Services to develop anthrax vaccines for the Strategic National Stockpile but the stock price plummeted $8.41 to $30.91.
Emergent BioSolutions will respond to anthrax vaccine notice
June 22, 2016 at 13:28 PM EDT
